Banque Cantonale Vaudoise’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-16
Closed -$6K 893
2024
Q2
$6K Hold
16
﹤0.01% 952
2024
Q1
$6K Hold
16
﹤0.01% 947
2023
Q4
$6K Hold
16
﹤0.01% 973
2023
Q3
$7K Sell
16
-14
-47% -$9.19K ﹤0.01% 1132
2023
Q2
$22K Hold
30
﹤0.01% 1060
2023
Q1
$23K Hold
30
﹤0.01% 1056
2022
Q4
$58K Hold
30
﹤0.01% 933
2022
Q3
$17K Hold
30
﹤0.01% 1111
2022
Q2
$23K Hold
30
﹤0.01% 1110
2022
Q1
$104K Buy
30
+7
+30% +$18.3K ﹤0.01% 918
2021
Q4
$69K Hold
23
﹤0.01% 1014
2021
Q3
$151K Hold
23
0.01% 866
2021
Q2
$306K Hold
23
0.01% 736
2021
Q1
$389K Hold
23
0.02% 604
2020
Q4
$391K Buy
23
+4
+21% +$75.3K 0.02% 568
2020
Q3
$361K Buy
+19
New +$437K 0.02% 526

Other funds holding KALA

Banque Cantonale Vaudoise's KALA Position: Q3 2024 in Review

Banque Cantonale Vaudoise sold out of KALA BIO (KALA) in Q3 2024, closing a stake of 16 shares — an estimated $6K sold.

Banque Cantonale Vaudoise first reported a position in KALA in Q3 2020 and held it in 16 quarters. The position peaked at $391K in Q4 2020. 22 funds tracked by Wall St. Rank hold KALA as of Q3 2024.

  • Banque Cantonale Vaudoise reported no remaining KALA BIO position as of Q3 2024 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 16 KALA BIO shares in Q3 2024, an estimated $6K.
  • Banque Cantonale Vaudoise first reported a position in KALA BIO in Q3 2020 and held it in 16 quarters.
  • Banque Cantonale Vaudoise's KALA BIO position peaked at $391K in Q4 2020.
  • 22 funds tracked by Wall St. Rank held KALA BIO as of Q3 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2024, filed 8 Nov 2024.